Mark Booth
Executive Vice President, Chief Commercial Officer
Mark Booth is Executive Vice President, Chief Commercial Officer of TerSera Therapeutics. Previously, Mark was Chief Commercial Officer at Assertio Therapeutics and Orexigen Therapeutics.
Mark has extensive leadership experience, having led multiple commercial organizations in big pharma, biopharma, and specialty pharmaceutical companies. Prior to Assertio and Orexigen, Mark was President of Takeda Pharmaceuticals North America for 7 years. He also served as General Manager and Senior Vice President of Commercial Operations at Immunex Corporation.
Mark began his pharmaceutical career at Abbott, and for over 17 years held multiple positions of increasing responsibility with his last role being Division Vice President, General Manager for the Anti-Infective Franchise.
Mark holds a BS from Northern Illinois University and an MBA from the Kellogg School of Management at Northwestern University.
